131I effective half-life and dosimetry in thyroid cancer patients.
Remy H, Borget I, Leboulleux S, Guilabert N, Lavielle F, Garsi J, Bournaud C, Gupta S, Schlumberger M, Ricard M.
Remy H, et al. Among authors: ricard m.
J Nucl Med. 2008 Sep;49(9):1445-50. doi: 10.2967/jnumed.108.052464. Epub 2008 Aug 14.
J Nucl Med. 2008.
PMID: 18703593
Free article.